查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1471959

蛋白質體學市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按產品和服務、應用、最終用戶和地理位置

Proteomics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

依據「2030 年蛋白質體學市場預測- COVID-19 影響和全球分析- 按產品和服務、應用程式和最終用戶分類」的新研究，該市場預計將從2022 年的270.7 億美元成長，並預計到2030年達到750.3億美元；預計2022-2030年複合年成長率為13.6%。市場成長歸因於慢性病病例的激增和奈米蛋白質組學的日益突出。不斷成長的技術進步和研發支出可能為蛋白質組學市場提供成長機會。然而，儀器成本高昂和技術人員缺乏阻礙了蛋白質體學市場的成長。

蛋白質體學，即蛋白質的詳細分析，已成為研究藥物開發、治療、預後和疾病特徵的重要領域。蛋白質體學技術有助於傳染性和非傳染性疾病的檢測和治療。透過使用奈米技術作為技術平台，目前的蛋白質體學方法變得更加可靠、生物相容性、特異性和可重複性。使用奈米材料透過蛋白質操作來提高蛋白質組技術的質量，大大評估了傳統蛋白質組技術的缺點。在製藥領域，蛋白質體學研究藥物作用或毒性機制。它們也廣泛用於識別和確認生物標記的有效性。

到2022年，北美將佔據全球蛋白質體市場的主要佔有率。推動該地區市場成長的關鍵因素是對基於結構的藥物設計開發的投資不斷增加、對資料可重複性的高品質研究工具的需求、組學研究的成長等。主要區域公司之間的夥伴關係和合作也有助於該地區的市場擴張。例如，Thermo Fisher Scientific Inc. 和 Symphogen 合作開發了經過驗證的平台流程，用於最佳化複雜治療性蛋白質的表徵和品質監控。此外，蛋白質體學研究在美國等國家正處於鼎盛時期。

不斷成長的技術進步和研發支出為未來提供市場機會

蛋白質組學行業的製造商致力於提供用於疾病診斷的新方法和設備。安捷倫科技公司等公司已經認知到使用技術外包策略專注於開發蛋白質分析產品的優勢。透過使用蛋白質體學技術，可以實現基於蛋白質的診斷的絕對定量。關鍵的蛋白質體學服務和其他技術，包括微陣列、X光晶體學、光譜技術、色譜、電泳和表面等離子體共振系統，構成了蛋白質組學市場的基礎。

蛋白質體學研究和開發的投資不斷增加正在促進市場成長。美國國立衛生研究院 (NIH) 撥款 370 億美元用於生物醫學研究。這筆資金將有助於研究疾病發展的基本機制，識別表明疾病存在的生物標記物，或識別導致疾病的基因或蛋白質。諾和諾德基金會向哥本哈根大學提供高達 150 萬美元的資助，用於建造質譜設施，這是蛋白質研究的重要一步。 COVID-19 爆發後，市場迅速成長。

關鍵參與者對於改善發展中國家人民獲得優質醫療保健和藥品的機會至關重要，這也擴大了發展中國家的經濟前景，他們也努力透過創造更多就業機會、進行大量投資、影響公共政策和提供培訓來增加經濟機會。製藥業對發展中國家經濟機會的成長有重大影響。近年來，製藥公司取得了優異的財務表現。例如，賽默飛世爾科技公司 (Thermo Fisher Scientific, Inc.) 去年公佈了創紀錄的利潤，預計未來業績會更好。隨著多家生物製藥公司逐漸成為主要參與者並且正在進行各種研發活動，該市場將繼續蓬勃發展，從而為全球市場提供成長機會。

基於產品和服務的見解

根據產品和服務，蛋白質體學市場分為儀器技術、試劑和耗材以及軟體和服務。試劑和耗材細分市場在 2022 年佔據最大的市場佔有率，並可能在 2022 年至 2030 年期間實現最高的複合年成長率，達到 14.1%。

試劑和試劑盒、耗材和試紙條擴大用於研究大學、研究機構和其他領域的各種生物材料的研究。政府在蛋白質體學和基因組學領域的措施正在推動疾病診斷的研究活動。 3D 電泳蛋白質分析儀等先進儀器的技術進步提高了生物研究的速度、效率和生產力，也推動了對試劑和耗材的需求。這些因素促進了該領域蛋白質體學市場規模的不斷成長。

基於應用程式的見解

該市場根據應用分為臨床診斷、藥物發現和開發等。臨床診斷領域在 2022 年佔據最大的蛋白質體學市場佔有率。

基於最終用戶的見解

根據最終用戶，市場分為製藥和生物技術公司、研究和臨床實驗室、醫院等。製藥和生物技術公司領域在 2022 年佔據最大的蛋白質組市場佔有率。

領先企業正在實施擴張、合作、推出新產品和獲取新客戶群等策略，以挖掘現有的商機。

2022 年 1 月，Seer, Inc. 宣布推出卓越中心計畫並商業發布 Proteograph 產品套件。 Proteograph 產品套件提供公正、無與倫比的蛋白質體存取。該方法使用獨特設計的奈米粒子來生產突破性產品，從而實現快速、徹底和公正的大規模蛋白質體學。

In February 2021, Agilent Technologies Inc. launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, designed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or電漿.

2021 年 2 月，Pochon Scientific, LLC 購買了一台新型 Thermo Orbitrap Exploris 240 質譜儀，該質譜儀具有 BioPharma 選項和 FAIMS Pro 介面。它是一款多功能、新一代高解析度質譜儀，可為蛋白質組學、代謝組學和生物製藥表徵提供卓越的性能。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 和全球疾病負擔研究是準備蛋白質體學市場報告時參考的主要和次要來源。

目錄

第 1 章：簡介

第 2 章：要點

第 3 章：研究方法

第 4 章：蛋白質體學市場格局

  • 概述
  • 害蟲分析
    • 北美 - 害蟲分析
    • 歐洲 - 害蟲分析
    • 亞太地區 - 害蟲分析
    • 中東和非洲 - 害蟲分析
    • 南美洲和中美洲 - 害蟲分析
  • 專家意見

第 5 章：蛋白質體學市場 - 主要市場動態

  • 主要市場促進因素
  • 主要市場限制
  • 主要市場機會
  • 未來的趨勢
  • 駕駛員和約束的影響分析

第 6 章：蛋白質體學市場 - 全球市場分析

  • 蛋白質體學 - 全球市場概覽
  • 蛋白質體學 - 全球市場與 2028 年預測
  • 市場定位

第 7 章：蛋白質體學市場 - 收入與 2028 年預測 - 工具

  • 概述
  • 儀器儀表市場預測與分析
  • 光譜學
    • 概述
    • 光譜市場預測與分析
    • 質譜市場
      • 概述
      • 質譜市場預測與分析
    • 核磁共振波譜市場
      • 概述
      • 核磁共振波譜市場預測與分析
    • 圓二色性 (CD) 光譜市場
      • 概述
      • 圓二色性 (CD) 光譜市場預測與分析
  • 色譜法
    • 概述
    • 色譜市場預測與分析
    • 高效液相層析市場
      • 概述
      • HPLC市場預測與分析
    • 離子色譜市場
      • 概述
      • 離子色譜市場預測與分析
    • 離子色譜市場
      • 概述
      • 離子色譜市場預測與分析
    • 超臨界流體層析市場
      • 概述
      • 超臨界流體色譜市場預測與分析
  • 電泳
    • 概述
    • 電泳市場預測與分析
    • 凝膠電泳市場
      • 概述
      • 凝膠電泳市場預測與分析
    • 毛細管電泳市場
      • 概述
      • 毛細管電泳市場預測與分析
  • 蛋白質微陣列
    • 概述
    • 蛋白質微陣列市場預測與分析
    • 生物晶片市場
      • 概述
      • 生物晶片市場預測與分析
    • 微陣列儀器市場
      • 概述
      • 微陣列儀器市場預測與分析
  • X光晶體學
    • 概述
    • X光晶體學市場預測與分析
  • 表面等離激元共振
    • 概述
    • 表面等離子共振市場預測與分析
  • 蛋白質分級分離
    • 概述
    • 蛋白質分離市場預測與分析
  • 其他樂器
    • 概述
    • 其他儀器市場預測與分析

第 8 章：蛋白質體學市場 - 收入和 2028 年預測 - 試劑

  • 概述
  • 試劑市場預測與分析
  • 免疫檢測試劑
    • 概述
    • 免疫分析試劑市場預測與分析
  • 光譜試劑
    • 概述
    • 光譜試劑市場預測與分析
  • 色譜試劑
    • 概述
    • 色譜試劑市場預測與分析
  • 蛋白質微陣列試劑
    • 概述
    • 蛋白質微陣列試劑市場預測與分析
  • X光晶體學試劑
    • 概述
    • X光晶體學試劑市場預測與分析
  • 電泳試劑
    • 概述
    • 電泳試劑市場預測與分析
  • 蛋白質分級試劑
    • 概述
    • 蛋白質分級試劑市場預測與分析

第 9 章：蛋白質體學市場 - 2028 年收入與預測 - 服務與軟體

  • 概述
  • 服務與軟體市場預測與分析
  • 服務
    • 概述
    • 服務市場預測與分析
    • 蛋白質鑑定服務市場
      • 概述
      • 蛋白質鑑定服務市場預測與分析
    • 定量蛋白質體學服務市場
      • 概述
      • 定量蛋白質體學服務市場預測與分析
    • 蛋白質純化服務市場
      • 概述
      • 蛋白質純化服務市場預測與分析
    • 蛋白質分離服務市場
      • 概述
      • 蛋白質分離服務市場預測與分析
    • 蛋白質定序服務市場
      • 概述
      • 蛋白質定序服務市場預測與分析
    • 其他服務市場
      • 概述
      • 其他服務市場預測與分析
  • 軟體
    • 概述
    • 軟體市場預測與分析
    • 生物資訊服務市場
      • 概述
      • 生物資訊服務市場預測與分析
    • 生物資訊工具市場
      • 概述
      • 生物資訊工具市場預測與分析
    • 生物資訊資料庫市場
      • 概述
      • 生物資訊資料庫市場預測與分析

第 10 章：蛋白質體學市場 - 2028 年收入與預測 - 應用

  • 概述
  • 應用市場預測與分析
  • 臨床診斷
    • 概述
    • 臨床診斷市場預測與分析
  • 藥物發現
    • 概述
    • 藥物發現市場預測與分析
  • 其他應用
    • 概述
    • 其他應用市場預測與分析

第 11 章：蛋白質體學市場收入和 2028 年預測 - 地理分析

  • 北美洲
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 歐洲
      • 德國
      • 法國
      • 義大利
      • 西班牙
      • 英國
      • 歐洲其他地區
  • 亞太
    • 亞太
      • 澳洲
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 中東和非洲
      • 南非
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 中東和非洲其他地區
  • 南美洲和中美洲
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地區

第 12 章：COVID-19 大流行對全球蛋白質體市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 中東和非洲
  • 南美洲和中美洲

第 13 章：產業格局

  • 併購
  • 協議、合作和合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 14 章：蛋白質體學市場，主要公司概況

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • AGILENT TECHNOLOGIES
  • DANAHER
  • PERKINELMER INC.
  • MERCK KGAA
  • LUMINEX CORPORATION
  • GENERAL ELECTRIC COMPANY
簡介目錄
Product Code: TIPHE100001115

According to our new research study on "Proteomics Market Forecast to 2030 - COVID-19 Impact and Global Analysis - by Product & Service, Application, and End User," the market is anticipated to grow from US$ 27.07 billion in 2022 and is projected to reach US$ 75.03 billion by 2030; it is expected to register a CAGR of 13.6% during 2022-2030. Market growth is attributed to the proliferating cases of chronic diseases and the growing prominence of nano proteomics. Growing technological advancements and R&D expenditure will likely provide growth opportunities for the proteomics market. However, the high costs of instruments and the dearth of skilled personnel hinder the growth of the proteomics market.

Proteomics, the detailed analysis of proteins, has become a significant field to study drug development, therapy, prognosis, and disease characterization. Proteomics technologies help with both infectious and noninfectious disease detection and therapy. The current proteomic methodologies are being made more reliable, biocompatible, specific, and reproducible through the use of nanotechnology as a technological platform. The shortcomings of conventional proteomic techniques are greatly assessed with the use of nanomaterials to enhance the quality of proteomic techniques by protein manipulation. In the pharmaceutical field, proteomics studies drug effects or the mechanism of toxicity. They are also widely used to identify and confirm the effectiveness of biomarkers.

North America accounted for a major share of the global proteomics market in 2022. The North American proteomics market is segmented into the US, Canada, and Mexico. The key factors driving the market growth in this region is the increasing investments in the development of structure-based drug design, demand for high-quality research tools for data reproducibility, growth in omics research, etc. Attention is being paid to the development of tailor-made treatments. Partnerships and collaborations between major regional companies also contribute to the market expansion in the region. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to develop verified platform processes for optimized characterization and quality monitoring of complex therapeutic proteins. Also, proteomics research is at its peak in countries like the US.

Growing Technological Advancements and R&D Expenditure to Provide Market Opportunities in the Future

Manufacturers in the proteomics industry are focused on providing new methods and devices for disease diagnosis. Companies such as Agilent Technologies, Inc. have recognized the advantages of using technology out-licensing strategies to focus on developing products for protein analysis. The absolute quantification of protein-based diagnostics was made possible through the use of proteomics technology. Key proteomic services and other technologies, including microarray, X-ray crystallography, spectroscopic techniques, chromatography, electrophoresis, and surface plasma resonance systems, form the foundation of the proteomics market.

The increasing investments in research and development in proteomics are fostering market growth. The US National Institutes of Health (NIH) gave US$ 37 billion for biomedical research. This funding will aid in studying the fundamental mechanisms of disease development, identifying biomarkers that indicate the presence of a disease, or identifying the gene or protein that causes the disease. The Novo Nordisk Foundation granted the University of Copenhagen a grant of up to US$ 1.5 million to build a mass spectrometry facility, an important step toward protein research. The market quickly gained momentum after the outbreak of COVID-19.

Key players are crucial in improving people's access to quality healthcare and medicines in developing countries, which also expands their economic prospects, and they are also working to increase economic opportunities by creating more jobs, making significant investments, influencing public policy, and providing trainings. The pharmaceutical industry has a significant impact on the growth of economic opportunities in developing countries. In recent years, pharmaceutical companies have achieved excellent financial results. For example, Thermo Fisher Scientific, Inc. posted record profits last year, and future performance is predicted to be even better. The market will continue to flourish as several biopharmaceutical companies are emerging as key players and various R&D activities are being conducted, thereby providing growth opportunities for the global market.

Product & Service -Based Insights

Based on product & service, the proteomics market is divided into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment held the largest market share in 2022 and is likely to register the highest CAGR of 14.1% during 2022-2030.

Reagents & kits, consumables, and strips are increasingly used for studying various biological materials in research universities, research institutions, and other areas. Government initiatives in the field of proteomics and genomics are propelling research activities in disease diagnostics. Technical advancements in advanced instruments, such as 3D electrophoresis protein analyzers, which increase biological research's speed, efficiency, and productivity, are also propelling the demand for reagents and consumables. These factors are contributing to the growing proteomics market size for the segment.

Application -Based Insights

The market, based on application, is divided into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest proteomics market share in 2022. However, the drug discovery & development segment is expected to register the highest CAGR of 14.4% during 2022-2030.

End User -Based Insights

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, others. The pharmaceutical & biotechnology companies segment held the largest proteomics market share in 2022. However, the research & clinical laboratories segment is estimated to register the highest CAGR of 14.5% during 2022-2030.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.

In January 2022, Seer, Inc. announced the debut of the Centers of Excellence program and the commercial release of the Proteograph Product Suite. The Proteograph Product Suite provides unbiased, unmatched access to the proteome. The approach uses uniquely designed nanoparticles to produce a breakthrough product that enables rapid, thorough, and unbiased large-scale proteomics.

In February 2021, Agilent Technologies Inc. launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit, designed for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma.

In February 2021, Poochon Scientific, LLC acquired a new Thermo Orbitrap Exploris 240 mass spectrometer that has BioPharma option and FAIMS Pro interface. It is a versatile, new-generation, high-resolution mass spectrometer that offers exceptional performance for proteomics, metabolomics, and biopharmaceutical characterization.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the proteomics market report.

Table Of Contents

1. INTRODUCTION

  • 1.1. SCOPE OF THE STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3. MARKET SEGMENTATION
    • 1.3.1 Proteomics Market - By Instrument
    • 1.3.2 Proteomics Market - By Reagents
    • 1.3.3 Proteomics Market - By Services and Software
    • 1.3.4 Proteomics Market - By Application
    • 1.3.5 Proteomics Market - By Region
      • 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

  • 4.1. OVERVIEW
  • 4.2. PEST ANALYSIS
    • 4.2.1 North America - Pest Analysis
    • 4.2.2 Europe - Pest Analysis
    • 4.2.3 Asia-Pacific - Pest Analysis
    • 4.2.4 Middle East and Africa - Pest Analysis
    • 4.2.5 South and Central America - Pest Analysis
  • 4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

  • 5.1. KEY MARKET DRIVERS
  • 5.2. KEY MARKET RESTRAINTS
  • 5.3. KEY MARKET OPPORTUNITIES
  • 5.4. FUTURE TRENDS
  • 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

  • 6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
  • 6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
  • 6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

  • 7.1. OVERVIEW
  • 7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
  • 7.3. SPECTROSCOPY
    • 7.3.1. Overview
    • 7.3.2. Spectroscopy Market Forecast and Analysis
    • 7.3.3. Mass Spectroscopy Market
      • 7.3.3.1. Overview
      • 7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
    • 7.3.4. NMR Spectroscopy Market
      • 7.3.4.1. Overview
      • 7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
    • 7.3.5. Circular Dichroism (CD) Spectroscopy Market
      • 7.3.5.1. Overview
      • 7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
  • 7.4. CHROMATOGRAPHY
    • 7.4.1. Overview
    • 7.4.2. Chromatography Market Forecast and Analysis
    • 7.4.3. HPLC Market
      • 7.4.3.1. Overview
      • 7.4.3.2. HPLC Market Forecast and Analysis
    • 7.4.4. Ion Chromatography Market
      • 7.4.4.1. Overview
      • 7.4.4.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.5. Ion Chromatography Market
      • 7.4.5.1. Overview
      • 7.4.5.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.6. Supercritical Fluid Chromatography Market
      • 7.4.6.1. Overview
      • 7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
  • 7.5. ELECTROPHORESIS
    • 7.5.1. Overview
    • 7.5.2. Electrophoresis Market Forecast and Analysis
    • 7.5.3. Gel Electrophoresis Market
      • 7.5.3.1. Overview
      • 7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
    • 7.5.4. Capillary Electrophoresis Market
      • 7.5.4.1. Overview
      • 7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
  • 7.6. PROTEIN MICROARRAYS
    • 7.6.1. Overview
    • 7.6.2. Protein Microarrays Market Forecast and Analysis
    • 7.6.3. Biochips Market
      • 7.6.3.1. Overview
      • 7.6.3.2. Biochips Market Forecast and Analysis
    • 7.6.4. Microarray Instruments Market
      • 7.6.4.1. Overview
      • 7.6.4.2. Microarray Instruments Market Forecast and Analysis
  • 7.7. X-RAY CRYSTALLOGRAPHY
    • 7.7.1. Overview
    • 7.7.2. X-Ray Crystallography Market Forecast and Analysis
  • 7.8. SURFACE PLASMON RESONANCE
    • 7.8.1. Overview
    • 7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
  • 7.9. PROTEIN FRACTIONATION
    • 7.9.1. Overview
    • 7.9.2. Protein Fractionation Market Forecast and Analysis
  • 7.10. OTHER INSTRUMENT
    • 7.10.1. Overview
    • 7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

  • 8.1. OVERVIEW
  • 8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
  • 8.3. IMMUNOASSAY REAGENTS
    • 8.3.1. Overview
    • 8.3.2. Immunoassay Reagents Market Forecast and Analysis
  • 8.4. SPECTROSCOPY REAGENTS
    • 8.4.1. Overview
    • 8.4.2. Spectroscopy Reagents Market Forecast and Analysis
  • 8.5. CHROMATOGRAPHY REAGENTS
    • 8.5.1. Overview
    • 8.5.2. Chromatography Reagents Market Forecast and Analysis
  • 8.6. PROTEIN MICROARRAY REAGENTS
    • 8.6.1. Overview
    • 8.6.2. Protein Microarray Reagents Market Forecast and Analysis
  • 8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
    • 8.7.1. Overview
    • 8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
  • 8.8. ELECTROPHORESIS REAGENTS
    • 8.8.1. Overview
    • 8.8.2. Electrophoresis Reagents Market Forecast and Analysis
  • 8.9. PROTEIN FRACTIONATION REAGENTS
    • 8.9.1. Overview
    • 8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

  • 9.1. OVERVIEW
  • 9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
  • 9.3. SERVICES
    • 9.3.1. Overview
    • 9.3.2. Services Market Forecast and Analysis
    • 9.3.3. Protein Identification Services Market
      • 9.3.3.1. Overview
      • 9.3.3.2. Protein Identification Services Market Forecast and Analysis
    • 9.3.4. Quantitative Proteomics Services Market
      • 9.3.4.1. Overview
      • 9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
    • 9.3.5. Protein Purification Services Market
      • 9.3.5.1. Overview
      • 9.3.5.2. Protein Purification Services Market Forecast and Analysis
    • 9.3.6. Protein Separation Services Market
      • 9.3.6.1. Overview
      • 9.3.6.2. Protein Separation Services Market Forecast and Analysis
    • 9.3.7. Protein Sequencing Services Market
      • 9.3.7.1. Overview
      • 9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
    • 9.3.8. Others Services Market
      • 9.3.8.1. Overview
      • 9.3.8.2. Others Services Market Forecast and Analysis
  • 9.4. SOFTWARE
    • 9.4.1. Overview
    • 9.4.2. Software Market Forecast and Analysis
    • 9.4.3. Bioinformatics Services Market
      • 9.4.3.1. Overview
      • 9.4.3.2. Bioinformatics Services Market Forecast and Analysis
    • 9.4.4. Bioinformatics Tools Market
      • 9.4.4.1. Overview
      • 9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
    • 9.4.5. Bioinformatics Databases Market
      • 9.4.5.1. Overview
      • 9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

  • 10.1. OVERVIEW
  • 10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
  • 10.3. CLINICAL DIAGNOSTICS
    • 10.3.1. Overview
    • 10.3.2. Clinical Diagnostics Market Forecast and Analysis
  • 10.4. DRUG DISCOVERY
    • 10.4.1. Overview
    • 10.4.2. Drug Discovery Market Forecast and Analysis
  • 10.5. OTHER APPLICATIONS
    • 10.5.1. Overview
    • 10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1 North America Proteomics Market Overview
    • 11.1.2 North America Proteomics Market Forecasts and Analysis
    • 11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
    • 11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Proteomics Market
        • 11.1.7.1.1 United States Proteomics Market by Instrument
        • 11.1.7.1.2 United States Proteomics Market by Reagents
        • 11.1.7.1.3 United States Proteomics Market by Services and Software
        • 11.1.7.1.4 United States Proteomics Market by Application
      • 11.1.7.2 Canada Proteomics Market
        • 11.1.7.2.1 Canada Proteomics Market by Instrument
        • 11.1.7.2.2 Canada Proteomics Market by Reagents
        • 11.1.7.2.3 Canada Proteomics Market by Services and Software
        • 11.1.7.2.4 Canada Proteomics Market by Application
      • 11.1.7.3 Mexico Proteomics Market
        • 11.1.7.3.1 Mexico Proteomics Market by Instrument
        • 11.1.7.3.2 Mexico Proteomics Market by Reagents
        • 11.1.7.3.3 Mexico Proteomics Market by Services and Software
        • 11.1.7.3.4 Mexico Proteomics Market by Application
  • 11.2. EUROPE
    • 11.2.1 Europe Proteomics Market Overview
    • 11.2.2 Europe Proteomics Market Forecasts and Analysis
    • 11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
    • 11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
    • 11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
    • 11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
      • 11.2.7.1 Germany Proteomics Market
        • 11.2.7.1.1 Germany Proteomics Market by Instrument
        • 11.2.7.1.2 Germany Proteomics Market by Reagents
        • 11.2.7.1.3 Germany Proteomics Market by Services and Software
        • 11.2.7.1.4 Germany Proteomics Market by Application
      • 11.2.7.2 France Proteomics Market
        • 11.2.7.2.1 France Proteomics Market by Instrument
        • 11.2.7.2.2 France Proteomics Market by Reagents
        • 11.2.7.2.3 France Proteomics Market by Services and Software
        • 11.2.7.2.4 France Proteomics Market by Application
      • 11.2.7.3 Italy Proteomics Market
        • 11.2.7.3.1 Italy Proteomics Market by Instrument
        • 11.2.7.3.2 Italy Proteomics Market by Reagents
        • 11.2.7.3.3 Italy Proteomics Market by Services and Software
        • 11.2.7.3.4 Italy Proteomics Market by Application
      • 11.2.7.4 Spain Proteomics Market
        • 11.2.7.4.1 Spain Proteomics Market by Instrument
        • 11.2.7.4.2 Spain Proteomics Market by Reagents
        • 11.2.7.4.3 Spain Proteomics Market by Services and Software
        • 11.2.7.4.4 Spain Proteomics Market by Application
      • 11.2.7.5 United Kingdom Proteomics Market
        • 11.2.7.5.1 United Kingdom Proteomics Market by Instrument
        • 11.2.7.5.2 United Kingdom Proteomics Market by Reagents
        • 11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
        • 11.2.7.5.4 United Kingdom Proteomics Market by Application
      • 11.2.7.6 Rest of Europe Proteomics Market
        • 11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
        • 11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
        • 11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
        • 11.2.7.6.4 Rest of Europe Proteomics Market by Application
  • 11.3. ASIA-PACIFIC
    • 11.3.1 Asia-Pacific Proteomics Market Overview
    • 11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
    • 11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
    • 11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
    • 11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
    • 11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
      • 11.3.7.1 Australia Proteomics Market
        • 11.3.7.1.1 Australia Proteomics Market by Instrument
        • 11.3.7.1.2 Australia Proteomics Market by Reagents
        • 11.3.7.1.3 Australia Proteomics Market by Services and Software
        • 11.3.7.1.4 Australia Proteomics Market by Application
      • 11.3.7.2 China Proteomics Market
        • 11.3.7.2.1 China Proteomics Market by Instrument
        • 11.3.7.2.2 China Proteomics Market by Reagents
        • 11.3.7.2.3 China Proteomics Market by Services and Software
        • 11.3.7.2.4 China Proteomics Market by Application
      • 11.3.7.3 India Proteomics Market
        • 11.3.7.3.1 India Proteomics Market by Instrument
        • 11.3.7.3.2 India Proteomics Market by Reagents
        • 11.3.7.3.3 India Proteomics Market by Services and Software
        • 11.3.7.3.4 India Proteomics Market by Application
      • 11.3.7.4 Japan Proteomics Market
        • 11.3.7.4.1 Japan Proteomics Market by Instrument
        • 11.3.7.4.2 Japan Proteomics Market by Reagents
        • 11.3.7.4.3 Japan Proteomics Market by Services and Software
        • 11.3.7.4.4 Japan Proteomics Market by Application
      • 11.3.7.5 South Korea Proteomics Market
        • 11.3.7.5.1 South Korea Proteomics Market by Instrument
        • 11.3.7.5.2 South Korea Proteomics Market by Reagents
        • 11.3.7.5.3 South Korea Proteomics Market by Services and Software
        • 11.3.7.5.4 South Korea Proteomics Market by Application
      • 11.3.7.6 Rest of Asia-Pacific Proteomics Market
        • 11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
        • 11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
        • 11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
        • 11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
  • 11.4. MIDDLE EAST AND AFRICA
    • 11.4.1 Middle East and Africa Proteomics Market Overview
    • 11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
    • 11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
    • 11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
    • 11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
    • 11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
      • 11.4.7.1 South Africa Proteomics Market
        • 11.4.7.1.1 South Africa Proteomics Market by Instrument
        • 11.4.7.1.2 South Africa Proteomics Market by Reagents
        • 11.4.7.1.3 South Africa Proteomics Market by Services and Software
        • 11.4.7.1.4 South Africa Proteomics Market by Application
      • 11.4.7.2 Saudi Arabia Proteomics Market
        • 11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
        • 11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
        • 11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
        • 11.4.7.2.4 Saudi Arabia Proteomics Market by Application
      • 11.4.7.3 U.A.E Proteomics Market
        • 11.4.7.3.1 U.A.E Proteomics Market by Instrument
        • 11.4.7.3.2 U.A.E Proteomics Market by Reagents
        • 11.4.7.3.3 U.A.E Proteomics Market by Services and Software
        • 11.4.7.3.4 U.A.E Proteomics Market by Application
      • 11.4.7.4 Rest of Middle East and Africa Proteomics Market
        • 11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
        • 11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
        • 11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
        • 11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
  • 11.5. SOUTH AND CENTRAL AMERICA
    • 11.5.1 South and Central America Proteomics Market Overview
    • 11.5.2 South and Central America Proteomics Market Forecasts and Analysis
    • 11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
    • 11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
      • 11.5.7.1 Brazil Proteomics Market
        • 11.5.7.1.1 Brazil Proteomics Market by Instrument
        • 11.5.7.1.2 Brazil Proteomics Market by Reagents
        • 11.5.7.1.3 Brazil Proteomics Market by Services and Software
        • 11.5.7.1.4 Brazil Proteomics Market by Application
      • 11.5.7.2 Argentina Proteomics Market
        • 11.5.7.2.1 Argentina Proteomics Market by Instrument
        • 11.5.7.2.2 Argentina Proteomics Market by Reagents
        • 11.5.7.2.3 Argentina Proteomics Market by Services and Software
        • 11.5.7.2.4 Argentina Proteomics Market by Application
      • 11.5.7.3 Rest of South and Central America Proteomics Market
        • 11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
        • 11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
        • 11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
        • 11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

  • 12.1 North America
  • 12.2 Europe
  • 12.3 Asia-Pacific
  • 12.4 Middle East and Africa
  • 12.5 South and Central America

13. INDUSTRY LANDSCAPE

  • 13.1. MERGERS AND ACQUISITIONS
  • 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
  • 13.3. NEW PRODUCT LAUNCHES
  • 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

  • 14.1. THERMO FISHER SCIENTIFIC INC.
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Products and Services
    • 14.1.4. Financial Overview
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. BIO-RAD LABORATORIES, INC.
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Products and Services
    • 14.2.4. Financial Overview
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. AGILENT TECHNOLOGIES
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Products and Services
    • 14.3.4. Financial Overview
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. DANAHER
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Products and Services
    • 14.4.4. Financial Overview
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. PERKINELMER INC.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Products and Services
    • 14.5.4. Financial Overview
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. MERCK KGAA
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Products and Services
    • 14.6.4. Financial Overview
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. LUMINEX CORPORATION
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Products and Services
    • 14.7.4. Financial Overview
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. GENERAL ELECTRIC COMPANY
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Products and S